{"disease":{"id":"anti-cancer-cell-immunotherapy","name":"anti cancer cell immunotherapy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03882840","title":"Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Second Affiliated Hospital of Guangzhou Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}